Life Science Company News

Reset
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Alvotech

ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  ProQR Therapeutics NV

Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®

Read more ››
By: GlobeNewswire - 19 Apr 2024

Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Ocugen, Inc.

Preliminary Results for the Year Ended 31 December 2023

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Biodexa Pharmaceuticals PLC

NeuroMetrix Announces Steps Taken to Enhance Shareholder Value

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  NeuroMetrix, Inc.

3Daughters Named “Startup of the Year” at BioLabs Philadelphia Investor Day 2024

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  3Daughters

VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023

Read more ››
By: GlobeNewswire - 19 Apr 2024

CorMedix Inc. Announces CMS Grants TDAPA to DefenCath

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  CorMedix Inc.

Lifeward Announces the Appointment of Mike Swinford to its Board of Directors

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  ReWalk Robotics Ltd.

PharmAla Closes Private Placement and Concurrent Debt Settlement

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  PharmAla Biotech

TScan Therapeutics Announces Closing of Upsized Public Offering

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  TScan Therapeutics, Inc.

Dr. Sam Barrell CBE appointed as CEO of LifeArc

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  LifeArc | LifeArc Centre for Therapeutics Discovery (CTD) | LifeArc Ventures

Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Zealand Pharma A/S

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Zealand Pharma A/S

LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  LeMaitre Vascular, Inc.

St. Vincent Regional Hospital Verified as Level I Trauma Center by American College of Surgeons

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Intermountain Healthcare Clinical Genetics Institute | Intermountain Healthcare

Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Bio-Path Holdings, Inc.

Carbios files its 2023 Universal Registration Document

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Carbios SA

Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Pharming Group N.V.
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »